|
|
|
|
|
|
|
|
open access
Conclusions
The three-weekly regimen of docetaxel in combination with carboplatin was feasible
and active as second-line treatment of platinum-sensitive ovarian, peritoneal and
Fallopian tube cancer. The major toxicity was neutropenia, while the frequency of
peripheral neuropathy was low.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.